Seiler R - Search Results

1

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.

Seiler R, Ashab HAD, Erho N, van Rhijn BWG, Winters B, Douglas J, Van Kessel KE, Fransen van de Putte EE, Sommerlad M, Wang NQ, Choeurng V, Gibb EA, Palmer-Aronsten B, Lam LL, Buerki C, Davicioni E, Sjödahl G, Kardos J, Hoadley KA, Lerner SP, McConkey DJ, Choi W, Kim WY, Kiss B, Thalmann GN, Todenhöfer T, Crabb SJ, North S, Zwarthoff EC, Boormans JL, Wright J, Dall'Era M, van der Heijden MS, Black PC. Seiler R, et al. Eur Urol. 2017 Oct;72(4):544-554. doi: 10.1016/j.eururo.2017.03.030. Epub 2017 Apr 5. Eur Urol. 2017. PMID: 28390739

2

Pelvic lymph nodes: distribution and nodal tumour burden of urothelial bladder cancer.

Seiler R, von Gunten M, Thalmann GN, Fleischmann A. Seiler R, et al. J Clin Pathol. 2010 Jun;63(6):504-7. doi: 10.1136/jcp.2009.075077. Epub 2010 Apr 3. J Clin Pathol. 2010. PMID: 20364028 Free PMC article.

3

Androgen receptors are differentially expressed in Gleason patterns of prostate cancer and down-regulated in matched lymph node metastases.

Fleischmann A, Rocha C, Schobinger S, Seiler R, Wiese B, Thalmann GN. Fleischmann A, et al. Among authors: seiler r. Prostate. 2011 Apr;71(5):453-60. doi: 10.1002/pros.21259. Epub 2010 Sep 28. Prostate. 2011. PMID: 20878946

4

Extracapsular extension but not the tumour burden of lymph node metastases is an independent adverse risk factor in lymph node-positive bladder cancer.

Seiler R, von Gunten M, Thalmann GN, Fleischmann A. Seiler R, et al. Histopathology. 2011 Mar;58(4):571-8. doi: 10.1111/j.1365-2559.2011.03778.x. Epub 2011 Mar 14. Histopathology. 2011. PMID: 21401697

5

Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.

Fleischmann A, Rotzer D, Seiler R, Studer UE, Thalmann GN. Fleischmann A, et al. Among authors: seiler r. Eur Urol. 2011 Aug;60(2):350-7. doi: 10.1016/j.eururo.2011.05.035. Epub 2011 May 25. Eur Urol. 2011. PMID: 21640482

6

MMP-2 and MMP-9 in lymph-node-positive bladder cancer.

Seiler R, Thalmann GN, Fleischmann A. Seiler R, et al. J Clin Pathol. 2011 Dec;64(12):1078-82. doi: 10.1136/jclinpath-2011-200153. Epub 2011 Jun 21. J Clin Pathol. 2011. PMID: 21693565

7

High CD10 expression predicts favorable outcome in surgically treated lymph node-positive bladder cancer patients.

Seiler R, von Gunten M, Thalmann GN, Fleischmann A. Seiler R, et al. Hum Pathol. 2012 Feb;43(2):269-75. doi: 10.1016/j.humpath.2011.04.030. Epub 2011 Aug 10. Hum Pathol. 2012. PMID: 21835428

8

Occlusion of seminal vesicles increases sexual activity in a mouse model.

Birkhäuser FD, Schumacher C, Seiler R, de Meuron L, Zehnder P, Roth B, Wetterwald A, Thalmann GN, Cecchini MG, Studer UE. Birkhäuser FD, et al. Among authors: seiler r. Eur Urol. 2012 Nov;62(5):855-62. doi: 10.1016/j.eururo.2012.04.036. Epub 2012 Apr 19. Eur Urol. 2012. PMID: 22552215

9

Local recurrence after retropubic radical prostatectomy for prostate cancer does not exclusively occur at the anastomotic site.

Nguyen DP, Giannarini G, Seiler R, Schiller R, Thoeny HC, Thalmann GN, Studer UE. Nguyen DP, et al. Among authors: seiler r. BJU Int. 2013 Aug;112(4):E243-9. doi: 10.1111/j.1464-410X.2012.11506.x. Epub 2012 Nov 27. BJU Int. 2013. PMID: 23186331

10

CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response.

Seiler R, Thalmann GN, Rotzer D, Perren A, Fleischmann A. Seiler R, et al. Mod Pathol. 2014 Jan;27(1):87-95. doi: 10.1038/modpathol.2013.125. Epub 2013 Jul 26. Mod Pathol. 2014. PMID: 23887292 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

392 results

Search Page